Table 2.
Number of patients | 53 |
Age (years) | |
• Range | 22–84 |
• Mean/standard deviation | 58.3 ± 12.5 |
Sex | |
• Men | 42 (79%) |
• Women | 11 (21%) |
Valves affected | 71 |
Aortic valves affected | 33/71 (47%) |
• Native valve | 25/33 |
• Artificial valve | 8/33 |
Mechanical valve | 5/8 |
Biological valve | 3/8 |
Mitral valves affected | 30/71 (42%) |
• Native valve | 25/30 |
• Mechanical valve | 5/30 |
Native tricuspid valve affected | 6/71 (8%) |
Native pulmonary valve affected | 2/71 (3%) |
Subvalvar localization | 3 |
• Ventricular septal defect | |
Etiology | |
• Streptococci | 15/53 (28%) |
• Staphylococci | 14/53 (26%) |
• Enterococcus faecalis | 10/53 (19%) |
• Pseudomonas stutzeri | 1/53 (2%) |
• Corynebacterium | 1/53. (2%) |
• Cardiobacterium | 1/53 (2%) |
• Haemophilus influenzae | 1/53 (2%) |
• Negative blood culture | 10/53 (19%) |